Obsidian Therapeutics
PrivateLast Round
Private Equity
Apr 14, 2026
Est. Valuation
$763.5M
Total Funding Raised
$325M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Obsidian Therapeutics is a biotechnology company that develops engineered cell and gene therapies for cancer treatment using a proprietary protein-regulation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Obsidian Therapeutics Comparables
Compare Obsidian Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Turnstone Biologics | 83% | |
| Iovance Biotherapeutics | 79% | |
| Intima Bioscience | 77% |
Obsidian Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Apr 14, 2026 | ||||
| Series C | Apr 3, 2024 | ||||
| Series B | Sep 9, 2021 | ||||
| Series A | Dec 6, 2017 |
Obsidian Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Private Equity |
| Soleus Capital | Series B |
| Surveyor Capital | Series C, Series B |
| Janus Henderson Group | Series C, Private Equity |
| Balyasny Asset Management L.P. | Private Equity |
| RA Capital Management | Series C, Series B, Private Equity |
| TCG Crossover | Series C, Private Equity, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
All-stock merger agreement with Galera Therapeutics announced.
- Apr 14, 2026
$350M raised in a Private Placement round.
Recent news
Latest coverage and updates
- goes_publicAug 5, 2026
Obsidian Therapeutics, Inc. went public on Aug 4th '26.
- receives_financingAug 5, 2026
Obsidian Therapeutics, Inc. received financing of $2.1M on Mar 1st '24.
Obsidian Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Obsidian Therapeutics's valuation, stock price, and market status.
Is Obsidian Therapeutics a public or private company?
Obsidian Therapeutics is a private company.
What is the current stock price of Obsidian Therapeutics?
Obsidian Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Obsidian Therapeutics worth (valuation)?
Valuation information for Obsidian Therapeutics is not publicly available.
Can I buy Obsidian Therapeutics stock?
Obsidian Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Obsidian Therapeutics's last funding round?
Obsidian Therapeutics's most recent funding round was Private Placement on April 14, 2026.
Who are the main investors in Obsidian Therapeutics?
Key investors in Obsidian Therapeutics include TCG Crossover, GV, Wellington Management.
Will Obsidian Therapeutics IPO soon?
No public IPO plans have been announced for Obsidian Therapeutics.
How can I track Obsidian Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Obsidian Therapeutics's secondary market activity and sign up for updates.